Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce W Bode

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Diabetes Care|July 12, 2014
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registryJenise C Wong, Nicole C Foster, David M Maahs, et al.
Diabetes Care|March 26, 2015
Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care 2014;37:2702-2709Jenise C Wong, Nicole C Foster, David M Maahs, et al.
Diabetes Technology & Therapeutics|January 31, 2017
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 DiabetesSatish K Garg, Stuart A Weinzimer, William V Tamborlane, et al.
Diabetes Care|February 18, 2017
REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 DiabetesGrazia Aleppo, Katrina J Ruedy, Tonya D Riddlesworth, et al.
Diabetes, Obesity & Metabolism|September 20, 2024
Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetesSarah A MacLeish, Korey K Hood, William H Polonsky, et al.
Diabetes Care|October 20, 2025
Erratum. Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial. Diabetes Care 2025;48:1598-1606Lauren V Turner, Jennifer L Sherr, Dessi P Zaharieva, et al.
Diabetes Care|July 18, 2025
Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled TrialLauren V Turner, Jennifer L Sherr, Dessi P Zaharieva, et al.
Pediatric Diabetes|April 30, 2025
Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their CaregiversKorey K Hood, William H Polonsky, Sarah A MacLeish, et al.
Diabetes Technology & Therapeutics|April 29, 2026
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 DiabetesHalis K Akturk, Laura M Nally, Rayhan A Lal, et al.
Diabetes Research and Clinical Practice|July 19, 2022
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 SystemWilliam H Polonsky, Korey K Hood, Carol J Levy, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Diabetes Care|July 12, 2014
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registryJenise C Wong, Nicole C Foster, David M Maahs, et al.
Diabetes Care|March 26, 2015
Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care 2014;37:2702-2709Jenise C Wong, Nicole C Foster, David M Maahs, et al.
Diabetes Technology & Therapeutics|January 31, 2017
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 DiabetesSatish K Garg, Stuart A Weinzimer, William V Tamborlane, et al.
Diabetes Care|February 18, 2017
REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 DiabetesGrazia Aleppo, Katrina J Ruedy, Tonya D Riddlesworth, et al.
Diabetes, Obesity & Metabolism|September 20, 2024
Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetesSarah A MacLeish, Korey K Hood, William H Polonsky, et al.
Diabetes Care|October 20, 2025
Erratum. Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial. Diabetes Care 2025;48:1598-1606Lauren V Turner, Jennifer L Sherr, Dessi P Zaharieva, et al.
Diabetes Care|July 18, 2025
Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled TrialLauren V Turner, Jennifer L Sherr, Dessi P Zaharieva, et al.
Pediatric Diabetes|April 30, 2025
Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their CaregiversKorey K Hood, William H Polonsky, Sarah A MacLeish, et al.
Diabetes Technology & Therapeutics|April 29, 2026
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 DiabetesHalis K Akturk, Laura M Nally, Rayhan A Lal, et al.
Diabetes Research and Clinical Practice|July 19, 2022
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 SystemWilliam H Polonsky, Korey K Hood, Carol J Levy, et al.
Pageof 13